Insight 10
Hair changes during and after cancer treatment
Last reviewed
Published
Hair effects during cancer care depend on the treatment. Sudden loss, gradual thinning, a different texture and changes in brows or lashes can occur at different stages.
Planning before treatment helps establish what protection or support is available. Later assessment needs the cancer treatment history alongside the actual hair and scalp findings.
Different treatments affect hair differently
Some chemotherapy disrupts hairs in active growth. Radiation affects hair in the treated area. Hair that returns can differ in texture or color. The National Cancer Institute describes these changes and practical care.1
Endocrine treatment for breast cancer can cause gradual thinning resembling pattern hair loss. A study of affected patients documented this appearance.2 A pre-existing hair disorder can also continue during cancer care.
Record the names and dates of treatments, including continuing tablets and targeted or immune therapies. New symptoms or an unusual local change still need their own assessment.
Discuss protection before treatment begins
Scalp cooling can reduce loss during some chemotherapy regimens. A randomized breast cancer trial found that more patients receiving cooling met the study's hair-preservation measure than those without cooling. The benefit varied among patients.3
Suitability depends on the cancer, regimen and device requirements. The oncology service should assess it before treatment starts. Regulatory information defines the intended use and restrictions of a cleared system.4
Separate device studies cannot establish that one system is better than another. The regimen and definition of success also need to be comparable.
Hair protection is easier to plan before the treatment expected to cause the loss.
Record recovery and persistent changes
Photographs before treatment establish a starting point. Later records can show where growth returns and whether hair remains finer in particular areas. Texture changes can affect handling even as coverage improves.
Persistent thinning or slow recovery deserves review. Assessment can consider ongoing treatment effects, nutritional circumstances and a separate hair disorder. There is no need to wait for extensive loss before seeking an explanation.
A persistent sore, firm spot or changing local patch needs medical examination. A distinct new finding deserves its own assessment alongside the cancer treatment history.
Fit support into the oncology plan
Gentle handling can reduce avoidable shaft damage. Wigs, scarves and other coverage can help during treatment and recovery.1 Fit and comfort matter on a tender scalp, and pulling or pressure should be addressed.
Drug, supplement and procedure recommendations need to fit the oncology plan. Include nonprescription products in the review. Decisions about changing cancer treatment belong with the oncology team.
Bring the treatment timeline, earlier photographs and the concern needing attention now. The hair recommendation should identify practical priorities and support coordinated care.
References
- National Cancer Institute. Hair Loss Alopecia and Cancer Treatment. https://www.cancer.gov/about-cancer/treatment/side-effects/hair-loss Return to text ↑
- Freites-Martinez A, Shapiro J, Chan D, et al. Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer. JAMA Dermatol. 2018;154:670-675. doi:10.1001/jamadermatol.2018.0454. Return to text ↑
- Nangia J, Wang T, Osborne C, et al. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial. JAMA. 2017;317:596-605. doi:10.1001/jama.2016.20939. Return to text ↑
- US Food and Drug Administration. DigniCap Scalp Cooling System 510k Summary K170871. https://www.accessdata.fda.gov/cdrh_docs/pdf17/K170871.pdf Return to text ↑
